We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Vaping Illness Characterized by Lipid-Laden Cells in Lungs

By LabMedica International staff writers
Posted on 17 Sep 2019
Print article
Image: Lipid-laden macrophages found in patients with vaping-related respiratory illness. Oily lipids are stained red (Photo courtesy of Andrew Hansen, MD, Jordan Valley Medical Center).
Image: Lipid-laden macrophages found in patients with vaping-related respiratory illness. Oily lipids are stained red (Photo courtesy of Andrew Hansen, MD, Jordan Valley Medical Center).
Lung scans from patients with vaping illness look like a serious viral or bacterial pneumonia, but those tests come back negative. Instead, diagnosis has been based on exclusion of known causes of similar respiratory illnesses combined with knowing the patient has a history of vaping.

Doctors have identified a previously unrecognized characteristic of the vaping-related respiratory illness that has been emerging in clusters across the USA in recent months. Within the lungs of these patients are large immune cells containing numerous oily droplets, called lipid-laden macrophages.

Physicians at the University of Utah Health (Salt Lake City, UT, USA) identified the lipid-laden macrophages in all six cases seen at University of Utah Hospital. The cells were found in samples after performing a procedure called bronchoalveolar lavage where fluid is squirted into a small section of the lungs and then collected for examination. Bronchoalveolar lavage (BAL) fluid showed neutrophilic predominance (49%) and more than 50% lipid-laden macrophages by oil red O staining. Staining them with this dye called highlighted the oily droplets littered throughout these cells. Testing of this fluid by culture and polymerase-chain-reaction assay for bacterial, fungal, and viral pathogens did not reveal any evidence of infection.

The question remains as to whether the vaping respiratory illness is a type of lipoid pneumonia. Despite similarities, there are also differences. Unlike the vaping illness, classic lipoid pneumonia is typically seen in older individuals, typically caused by accidentally breathing in oil-based laxatives. Classic lipoid pneumonia also presents differently on x-rays of the lungs. Additional testing will need to be done to determine whether the vaping illness can be categorized as a new kind of lipoid pneumonia.

Scott Aberegg, MD, a critical care pulmonologist and senior author of the study, said, “While it is too soon to be sure, these lipid-laden macrophages may turn out to be useful to confirm or rule out this disease. They may also be helpful in understanding what is causing this illness. These cells are very distinctive, and we don't often see them. That made everybody start to think carefully about why they were there. Are they scavenging debris in the lungs that was introduced through vaping? We need to determine if these cells are specific for the illness or whether they are also seen in vaping patients who are not ill and don't have symptoms. If they are only seen in patients who get sick, we can begin to make some connections between what we're seeing in the lipid laden macrophages and whatever components of the vaping oils may be causing this syndrome.” The study was published on September 6, 2019, in the journal The New England Journal of Medicine.

Related Links:
University of Utah Health

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.